CHRNA7 and obesity disorder: Activating α7-nAChR may not only reduce obesity related insulin resistance by anti-inflammation mechanism [44], [53], but also ameliorate non-obese or low inflammation related insulin resistance through STAT3 related direct or indirect pathway.